Organisations source: ARIS

University of Ljubljana, Faculty of Pharmacy

Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
B740  Biomedical sciences  Pharmacological sciences, pharmacognosy, pharmacy, toxicology 
T410  Technological sciences  Pharmaceuticals and related technologies 
T390  Technological sciences  Polymer technology, biopolymers 
P310  Natural sciences and mathematics  Proteins, enzymology 
P390  Natural sciences and mathematics  Organic chemistry 

Code Description
2  Research 
3  Education 
Evaluation (metodology)
source: COBISS
Evaluation of bibliographic research performance indicators according to ARIS methodology
Points
53,014
A''
7,970.25
A'
28,406.25
A1/2
36,564.51
CI10
64,303
CImax
1,430
h10
101
A1
189.3
A3
39.16
Data for the last 5 years (citations for the last 10 years) on December 9, 2025; Data for score A3 calculation refer to period 2020-2024
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 3,265  81,533  72,113  22.09 
Scopus 3,366  91,924  81,883  24.33 
Research groups (2)
no. Code Name of group Responsible person No. of publications
1. 0787-001  Chair of Pharmaceutical technology and Pharmacotherapy  PhD Mitja Kos   5,423 
2. 0787-002  Chair for Pharmaceutical Chemistry  PhD Stanislav Gobec   12,800 
Researchers (180)
no. Code Name and surname Research area Status No. of publications
1. 58954  Boštjan Adamlje  Pharmacy  Researcher  0 
2. 15490  PhD Pegi Ahlin Grabnar  Pharmacy  Researcher  234 
3. 21456  PhD Marko Anderluh  Pharmacy  Researcher  405 
4. 59824  Klemen Bele  Pharmacy  Researcher  0 
5. 59635  Pia Berglez  Pharmacy  Researcher  8 
6. 38497  PhD Maja Bjelošević Žiberna  Pharmacy  Researcher  106 
7. 11124  PhD Marija Bogataj  Pharmacy  Researcher  384 
8. 32694  PhD Katarina Bolko Seljak  Pharmacy  Researcher  62 
9. 00781  PhD Borut Božič  Microbiology and immunology  Researcher  622 
10. 15637  PhD Mojca Božič Mijovski  Cardiovascular system  Researcher  244 
11. 23598  PhD Tomaž Bratkovič  Pharmacy  Researcher  261 
12. 53656  PhD Aleša Bricelj  Pharmacy  Researcher  41 
13. 57938  Tilen Burnik  Pharmacy  Researcher  14 
14. 26227  Manja Cedilnik    Junior expert or technical associate  0 
15. 59468  Zala Celan    Junior expert or technical associate  0 
16. 60496  Eva Cencič  Pharmacy  Researcher  0 
17. 61036  Jernej Cingl  Pharmacy  Researcher  0 
18. 17432  Margareta Cof    Junior expert or technical associate  0 
19. 37459  PhD Andrej Emanuel Cotman  Chemistry  Researcher  84 
20. 19281  PhD Zdenko Časar  Chemistry  Researcher  181 
21. 34096  PhD Nanča Čebron Lipovec  Pharmacy  Researcher  87 
22. 15099  PhD Darko Černe  Pharmacy  Researcher  269 
23. 16362  PhD Saša Čučnik  Microbiology and immunology  Researcher  429 
24. 59572  Tilen Čuš  Pharmacy  Researcher  2 
25. 60479  Sara Damiani  Pharmacy  Researcher  0 
26. 54784  PhD Jaka Dernovšek  Pharmacy  Researcher  66 
27. 19785  PhD Bojan Doljak  Pharmacy  Researcher  270 
28. 21455  PhD Rok Dreu  Pharmacy  Researcher  299 
29. 61285  Žiga Duša  Pharmacy  Researcher  0 
30. 57579  Ivan Džajić  Pharmacy  Researcher  4 
31. 61337  Ema Faganeli  Pharmacy  Researcher  0 
32. 52168  Tjaša Felicijan  Pharmacy  Researcher  35 
33. 55890  PhD Svit Ferjančič Benetik  Pharmacy  Researcher  25 
34. 31879  Petra Ferkov    Junior expert or technical associate  0 
35. 57970  MSc Marzia Fois  Pharmacy  Researcher  11 
36. 34841  Maja Frelih  Forestry, wood and paper technology  Junior expert or technical associate  16 
37. 26512  PhD Rok Frlan  Pharmacy  Researcher  129 
38. 18700  Valerija Garb    Junior expert or technical associate  0 
39. 11789  PhD Mirjana Gašperlin  Pharmacy  Researcher  625 
40. 50713  Katja Glinšek  Pharmacy  Researcher  4 
41. 58034  Klemen Gnidovec  Pharmacy  Researcher  8 
42. 32034  PhD Martina Gobec  Oncology  Researcher  223 
43. 15284  PhD Stanislav Gobec  Pharmacy  Researcher  918 
44. 29887  PhD Mirjam Gosenca Matjaž  Pharmacy  Researcher  168 
45. 60914  Gordana Gosheva  Pharmacy  Researcher  0 
46. 16107  PhD Iztok Grabnar  Pharmacy  Researcher  465 
47. 58037  Nina Gradišek  Pharmacy  Researcher  7 
48. 51457  PhD Blaž Grilc  Pharmacy  Researcher  52 
49. 55103  Nina Katarina Grilc  Pharmacy  Researcher  35 
50. 52093  PhD Andrej Grobin  Pharmacy  Researcher  18 
51. 60003  Gašper Grošelj  Pharmacy  Researcher  0 
52. 52379  PhD Samo Guzelj  Pharmacy  Researcher  28 
53. 29979  PhD Nejc Horvat  Pharmacy  Researcher  110 
54. 55893  PhD Selena Horvat  Pharmacy  Researcher  32 
55. 32036  PhD Martina Hrast Rambaher  Pharmacy  Researcher  197 
56. 17433  Tatjana Hrovatič    Junior expert or technical associate  0 
57. 24400  PhD Janez Ilaš  Pharmacy  Researcher  284 
58. 26496  PhD Žiga Jakopin  Pharmacy  Researcher  223 
59. 56838  Špela Janež  Pharmacy  Researcher  18 
60. 34670  PhD Biljana Janković  Pharmacy  Researcher  143 
61. 55891  Nuša Japelj  Pharmacy  Researcher  28 
62. 56841  Ana Jug  Pharmacy  Researcher  5 
63. 27741  PhD Simona Jurković Mlakar  Pharmacy  Researcher  122 
64. 18619  PhD Maša Kandušer  Pharmacy  Researcher  179 
65. 21459  PhD Nataša Karas Kuželički  Pharmacy  Researcher  201 
66. 56840  Vid Kavaš  Pharmacy  Researcher  8 
67. 20370  PhD Mojca Kerec Kos  Pharmacy  Researcher  280 
68. 18699  Mojca Keržan    Junior expert or technical associate  0 
69. 59828  Klemen Kirbus  Pharmacy  Researcher  17 
70. 21692  Irena Klančnik Mavec    Junior expert or technical associate  0 
71. 36438  PhD Damijan Knez  Pharmacy  Researcher  276 
72. 29281  PhD Lea Knez  Pharmacy  Researcher  254 
73. 24402  PhD Petra Kocbek  Pharmacy  Researcher  330 
74. 61037  Metka Kocjančič  Pharmacy  Researcher  0 
75. 26495  PhD Nina Kočevar Glavač  Pharmacy  Researcher  276 
76. 55892  Anja Kodila  Pharmacy  Researcher  9 
77. 35028  PhD Ana Kodrič  Pharmacy  Researcher  61 
78. 30815  PhD Meta Kokalj Ladan  Pharmacy  Researcher  36 
79. 59722  Jakob Kolar  Pharmacy  Researcher  0 
80. 17434  Mihaela Kolarev    Junior expert or technical associate  0 
81. 23364  PhD Petra Kolenc Peitl  Pharmacy  Researcher  142 
82. 60667  Natan Koraj  Pharmacy  Researcher  2 
83. 04648  PhD Janko Kos  Biotechnical sciences  Researcher  1,244 
84. 20374  PhD Mitja Kos  Pharmacy  Researcher  511 
85. 33908  PhD Urban Košak  Pharmacy  Researcher  75 
86. 60602  Pija Košir  Pharmacy  Researcher  0 
87. 55572  PhD Alen Krajnc  Pharmacy  Researcher  39 
88. 53673  Nika Kržišnik  Pharmacy  Researcher  46 
89. 60498  Zala Kulovec  Pharmacy  Researcher  0 
90. 61254  Vid Kuralt  Pharmacy  Researcher  0 
91. 32037  PhD Zoran Lavrič  Pharmacy  Researcher  74 
92. 17430  Nevenka Lilik    Junior expert or technical associate  0 
93. 24399  PhD Igor Locatelli  Pharmacy  Researcher  314 
94. 19649  PhD Marija Nika Lovšin  Microbiology and immunology  Researcher  141 
95. 57531  David Lukić  Pharmacy  Researcher  4 
96. 25096  PhD Mojca Lunder  Pharmacy  Researcher  273 
97. 12189  PhD Janja Marc  Metabolic and hormonal disorders  Researcher  742 
98. 34223  PhD Tijana Markovič  Pharmacy  Researcher  77 
99. 58033  Peter Mastnak-Sokolov  Pharmacy  Researcher  0 
100. 53777  Mateja Matjaž    Junior expert or technical associate  0 
101. 53584  PhD Anže Meden  Pharmacy  Researcher  78 
102. 36440  PhD Ana Mitrović  Pharmacy  Researcher  145 
103. 60497  Karmen Mlinar  Pharmacy  Researcher  0 
104. 12443  PhD Irena Mlinarič Raščan  Pharmacy  Researcher  575 
105. 23419  PhD Janez Mravljak  Pharmacy  Researcher  234 
106. 19061  PhD Aleš Obreza  Pharmacy  Researcher  364 
107. 32693  PhD Jasna Omersel  Pharmacy  Researcher  94 
108. 10691  PhD Joško Osredkar  Human reproduction  Researcher  1,353 
109. 18154  PhD Barbara Ostanek  Metabolic and hormonal disorders  Researcher  212 
110. 60298  Andraž Oštrek, Ph.D.  Pharmacy  Researcher  14 
111. 28861  PhD Stane Pajk  Pharmacy  Researcher  238 
112. 57678  Emiliano Paradiso  Pharmacy  Researcher  3 
113. 19170  PhD Urša Pečar Fonović  Pharmacy  Researcher  164 
114. 60478  Matija Pečnik  Pharmacy  Researcher  0 
115. 37648  Katja Perc    Junior expert or technical associate  11 
116. 19317  PhD Lucija Peterlin Mašič  Pharmacy  Researcher  442 
117. 55894  PhD Martina Piga  Pharmacy  Researcher  33 
118. 32035  PhD Anja Pišlar  Biotechnology  Researcher  213 
119. 61336  Lara Planinc  Pharmacy  Researcher  0 
120. 14935  PhD Odon Planinšek  Pharmacy  Researcher  466 
121. 52446  Timeja Planinšek Parfant  Pharmacy  Researcher  46 
122. 51651  PhD Tina Vida Plavec  Biotechnology  Researcher  65 
123. 59866  Eva Podgoršek  Pharmacy  Researcher  6 
124. 59636  Pika Pollak Sicherl  Pharmacy  Researcher  5 
125. 37548  PhD Tanja Potrč  Pharmacy  Researcher  47 
126. 56839  Monika Prašnikar  Pharmacy  Researcher  21 
127. 52376  PhD Matic Proj  Pharmacy  Researcher  81 
128. 55895  PhD Edvin Purić  Pharmacy  Researcher  13 
129. 30708  PhD Petra Ratajc  Pharmacy  Researcher  19 
130. 56837  Nina Ravbar  Pharmacy  Researcher  11 
131. 29603  PhD Matjaž Ravnikar  Pharmacy  Researcher  75 
132. 50626  PhD Jernej Repas  Pharmacy  Researcher  38 
133. 60499  Neža Rogelj Meljo  Pharmacy  Researcher  0 
134. 23549  PhD Robert Roškar  Pharmacy  Researcher  353 
135. 58036  Žana Rus  Metabolic and hormonal disorders  Researcher  6 
136. 54785  PhD Katja Schoss  Pharmacy  Researcher  47 
137. 59874  Petra Seliškar  Pharmacy  Researcher  0 
138. 60495  Eva Simončič  Pharmacy  Researcher  0 
139. 19786  Majda Sirnik    Junior expert or technical associate  0 
140. 55140  Lara Smrdel  Pharmacy  Researcher  26 
141. 08519  PhD Marija Sollner Dolenc  Pharmacy  Researcher  704 
142. 30816  PhD Izidor Sosič  Pharmacy  Researcher  299 
143. 25490  PhD Matej Sova  Pharmacy  Researcher  178 
144. 34299  PhD Barbara Sterle Zorec  Pharmacy  Researcher  54 
145. 52378  PhD Nika Strašek Benedik  Pharmacy  Researcher  45 
146. 59723  Anja Suhadolc  Pharmacy  Researcher  8 
147. 60312  Lana Svečko  Pharmacy  Researcher  0 
148. 29982  PhD Alenka Šmid  Pharmacy  Researcher  142 
149. 07849  PhD Borut Štrukelj  Biochemistry and molecular biology  Researcher  1,165 
150. 58129  Pia Štrukelj Pahović  Chemistry  Researcher  8 
151. 26198  PhD Urban Švajger  Microbiology and immunology  Researcher  232 
152. 33335  PhD Eva Tavčar  Pharmacy  Researcher  99 
153. 35325  Martina Tekavec    Junior expert or technical associate  0 
154. 38166  PhD Žane Temova Rakuša  Pharmacy  Researcher  59 
155. 28334  PhD Tihomir Tomašić  Pharmacy  Researcher  445 
156. 58038  Gašper Tomšič  Pharmacy  Researcher  17 
157. 53933  PhD Armando Tratenšek  Pharmacy  Researcher  14 
158. 30817  PhD Tina Trdan Lušin  Natural sciences and mathematics  Researcher  46 
159. 23420  PhD Jurij Trontelj  Pharmacy  Researcher  291 
160. 59540  Natalija Trunkelj  Pharmacy  Researcher  0 
161. 34512  PhD Dunja Urbančič  Pharmacy  Researcher  98 
162. 01878  PhD Uroš Urleb  Pharmacy  Researcher  388 
163. 59724  Blaž Videčnik  Pharmacy  Researcher  0 
164. 54024  Mercedes Vitek  Pharmacy  Researcher  33 
165. 18155  PhD Tomaž Vovk  Pharmacy  Researcher  259 
166. 53726  PhD Lucija Ana Vrščaj  Metabolic and hormonal disorders  Researcher  46 
167. 54787  PhD Veronika Weiss  Pharmacy  Researcher  8 
168. 61338  Kaja Zajc  Pharmacy  Researcher  3 
169. 53670  PhD Živa Zajec  Pharmacy  Researcher  37 
170. 17438  Damijana Zalar    Junior expert or technical associate  0 
171. 53234  MSc Maja Zalokar  Natural sciences and mathematics  Junior expert or technical associate  49 
172. 18633  PhD Anamarija Zega  Pharmacy  Researcher  197 
173. 53870  PhD Anže Zidar  Pharmacy  Researcher  48 
174. 28905  PhD Nace Zidar  Pharmacy  Researcher  265 
175. 32306  PhD Janja Zupan  Metabolic and hormonal disorders  Researcher  149 
176. 58035  Ana Zupančič  Pharmacy  Researcher  11 
177. 36439  PhD Špela Zupančič  Pharmacy  Researcher  164 
178. 26226  PhD Alenka Zvonar Pobirk  Pharmacy  Researcher  242 
179. 22659  PhD Simon Žakelj  Pharmacy  Researcher  172 
180. 29416  PhD Lovro Žiberna  Neurobiology  Researcher  287 
Research projects (198) Legend
no. Code Title Period Responsible person No. of publications
1. N1-0417  Mono- and multivalent inhibitors of galectin-8 in tumour-associated (lymph)angiogenesis (MULTIGAL-8)  3/1/2025 - 9/30/2028  PhD Marko Anderluh   860 
2. N1-0411  Two-photon-activated targeted cancer therapies  3/1/2025 - 2/29/2028  PhD Anja Pišlar   1,305 
3. J3-60066  Advanced post-neoadjuvant treatment of early triple negative breast cancer (TNBC) with autologous cell immunotherapy  1/1/2025 - 12/31/2027  PhD Simona Borštnar   2,929 
4. J1-60023  Boosting Our Resolve against Carbapenemase-Resistance with boron-containing therapeutics  1/1/2025 - 12/31/2027  PhD Alen Krajnc   2,298 
5. J3-60067  Cathepsin Targeted Immunotherapy for Pancreatic Cancer Treatment -CATIMMPACT  1/1/2025 - 12/31/2027  PhD Milica Perišić Nanut   2,329 
6. J3-60060  Extracellular vesicles from recombinant Lactococcus lactis as novel protein delivery vectors for treatment of intestinal inflammation and prevention of colorectal cancer  1/1/2025 - 12/31/2027  PhD Tina Vida Plavec   1,262 
7. J2-60047  Magnetic micro-structuring of the Mg alloy surfaces for improved endothelialization and retained degradability of vascular stent materials  1/1/2025 - 12/31/2027  PhD Slavko Kralj   3,586 
8. N1-0331  A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases  1/1/2024 - 12/31/2027  PhD Izidor Sosič   1,137 
9. BI-JP/25-27-004  Synovial stem cells as treatment tools for degenerative joint diseases and injuries  4/1/2025 - 3/31/2027  PhD Janja Zupan   149 
10. N1-0363  Bisphenol A substitutes: health risks to the endocrine and cardiovascular systems (Acronim: BPAsubRisk)  3/1/2024 - 2/28/2027  PhD Marija Sollner Dolenc   1,839 
11. BI-NO/25-27-006  Evaluation of academic libraries to develop new antibacterial compounds  1/1/2025 - 12/31/2026  PhD Rok Frlan   129 
12. BI-VB/25-27-002  Tackling carbapenemase-mediated resistance to beta-lactam antibiotics  1/1/2025 - 12/31/2026  PhD Alen Krajnc   39 
13. J1-50038  New Hsp90 Inhibitor-based Therapies for Ewing Sarcoma  1/1/2024 - 12/31/2026  PhD Tihomir Tomašić   1,247 
14. J1-50023  3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation  10/1/2023 - 9/30/2026  PhD Andrej Emanuel Cotman   1,243 
15. J3-50099  A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking  10/1/2023 - 9/30/2026  PhD Peter Korošec   1,777 
16. J3-50123  Bacterial Biofilm Formation Inhibitors: A Novel Approach to Combat Antimicrobial Resistance  10/1/2023 - 9/30/2026  PhD Martina Hrast Rambaher   2,647 
17. J1-50039  Breaking the Walls: Development of Inhibitors of D,D- and L,D-Transpeptidases  10/1/2023 - 9/30/2026  PhD Stanislav Gobec   4,136 
18. J1-50037  Development of CDK1-selective degraders for the treatment of T-cell malignancies  10/1/2023 - 9/30/2026  PhD Izidor Sosič   1,331 
19. L7-50044  Efficacy and safety of dietary supplementation in targeting sleep quality: an evidence-based approach for supporting informed choices  10/1/2023 - 9/30/2026  PhD Igor Pravst   4,086 
20. J3-50116  Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors  10/1/2023 - 9/30/2026  PhD Martina Gobec   2,485 
21. J4-50139  Valorization of Himalayan balsam (Impatiens glandulifera Royle) waste to design bioactive extracts with a potential protective activity on the human vascular system  10/1/2023 - 9/30/2026  PhD Alen Albreht   1,509 
22. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy  10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,835 
23. J3-4496  Next-generation adjuvants for mucosal vaccines  10/1/2022 - 9/30/2026  PhD Žiga Jakopin   1,486 
24. BI-US/24-26-098  Mechanistic characterization of protein degraders with anti-cancer activity  7/1/2024 - 6/30/2026  PhD Izidor Sosič   299 
25. BI-US/24-26-032  Periphery in the center: Inclusion and exclusion of anthropology researchers in leading international scientific activities  7/1/2024 - 6/30/2026  PhD Dan Podjed   735 
26. BI-US/24-26-069  Structure-based discovery of new small molecule Hv1 proton channel inhibitors  7/1/2024 - 6/30/2026  PhD Nace Zidar   265 
27. BI-US/24-26-033  Unraveling Hsp90 inhibitor binding modes for rational anticancer drug design  7/1/2024 - 6/30/2026  PhD Tihomir Tomašić   445 
28. BI-JP/24-26-003  Structure-based discovery of novel Hv1 proton channel inhibitors  4/1/2024 - 4/1/2026  PhD Nace Zidar   265 
29. BI-FR/24-25-PROTEUS-003  Antibiotic adjuvants – Translocation of novel (cyclic boron-based) β-lactamase inhibitors across OmpF/OmpC porin channels and subcellular quantification of in enterobacteria  1/1/2025 - 12/31/2025  PhD Alen Krajnc   39 
30. BI-FR/24-25-PROTEUS-002  Identification of small molecule inhibitors for the development of new antibacterial drugs  1/1/2025 - 12/31/2025  PhD Rok Frlan   129 
31. BI-FR/24-25-PROTEUS-003  Antibiotic adjuvants: translocation of boron-containing β-lactamase inhibitors via OmpF/OmpC porin channels and their subcellular quantification in Enterobacteria  1/1/2024 - 12/31/2025  PhD Alen Krajnc   39 
32. BI-FR/24-25-PROTEUS-002  Identification of low molecular weight inhibitors for the development of new antibacterial drugs  1/1/2024 - 12/31/2025  PhD Rok Frlan   129 
33. BI-RS/23-25-016  Confronting multidrug-resistant Acinetobacter baumanii infection by DNA gyrase and topoisomerase inhibitors  7/1/2023 - 12/31/2025  PhD Žiga Jakopin   223 
34. BI-RS/23-25-018  The use of active cosmetic ingredients from botanical origin for lowering the synthetic preserves in cosmetic products  7/1/2023 - 12/31/2025  PhD Samo Kreft   801 
35. N1-0277  Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease  1/1/2023 - 12/31/2025  PhD Stanislav Gobec   1,423 
36. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms  12/1/2021 - 11/30/2025  PhD Stane Pajk   2,925 
37. L4-4564  Biotehnological potential of selected microorganisms from Sečovlje Saltpans for application in cosmetics products  10/1/2022 - 9/30/2025  PhD Ana Rotter   3,136 
38. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy  10/1/2022 - 9/30/2025  PhD Matej Sova   4,372 
39. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors  10/1/2022 - 9/30/2025  PhD Andrej Perdih   2,957 
40. J1-4400  Evaluation of transient protein states  10/1/2022 - 9/30/2025  PhD Simona Golič Grdadolnik   3,562 
41. J3-4499  MECHANISMS OF RESPONSE TO INTERLEUKIN 12/23 BLOCKERS IN ULCERATIVE COLITS – TOWARDS PERSONALIZED MEDICINE  10/1/2022 - 9/30/2025  PhD David Drobne   2,804 
42. J3-4527  Muscle cell secretom and bone cells interplay in osteosarcopenia (MiKOSA)  10/1/2022 - 9/30/2025  PhD Janja Marc   3,917 
43. J7-4418  Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections  10/1/2022 - 9/30/2025  PhD Špela Zupančič   6,041 
44. J4-4556  New biofertilization approach based on the microbial multispecies biocatalytic aggregates  10/1/2022 - 9/30/2025  PhD Tomaž Rijavec   7,011 
45. J1-4414  ProBiS-Fold approach for binding site detection for whole structural human proteome in drug discovery  10/1/2022 - 9/30/2025  PhD Dušanka Janežič   2,311 
46. L2-4455  Quantitative light scattering spectroscopy as a process analytical technology in pharmaceutical manufacturing  10/1/2022 - 9/30/2025  PhD Franjo Pernuš   2,766 
47. J2-4480  Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma)  10/1/2022 - 9/30/2025  PhD Martin Petkovšek   3,195 
48. J7-4420  Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles  10/1/2022 - 9/30/2025  PhD Aleš Berlec   4,375 
49. J3-3062  Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer  10/1/2021 - 9/30/2025  PhD Matjaž Jeras   2,786 
50. J1-3031  Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance  10/1/2021 - 9/30/2025  PhD Nace Zidar   1,191 
51. J2-3043  Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases  10/1/2021 - 9/30/2025  PhD Slavko Kralj   4,970 
52. J1-3030  MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance  10/1/2021 - 9/30/2025  PhD Lucija Peterlin Mašič   1,102 
53. BI-HR/23-24-031  Development of nanomedicines with poorly soluble drugs for ocular application  4/1/2023 - 3/31/2025  PhD Petra Kocbek   330 
54. BI-HR/23-24-032  Evaluation of harmine analogues as potential Hsp90 inhibitors against pediatric sarcomas  4/1/2023 - 3/31/2025  PhD Tihomir Tomašić   445 
55. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy  10/1/2021 - 3/31/2025  PhD Ana Mitrović   2,886 
56. BI-TR/22-24-007  Antimicrobial activity evaluation of natural and synthetic cinnamic acid derivatives against human and fish pathogens and their potential use as additives in fish feed  1/1/2023 - 12/31/2024  PhD Matej Sova   178 
57. BI-DE/23-24-011  Computer-aided design, synthesis and biological evaluation of Toll-like receptor 8 modulators  1/1/2023 - 12/31/2024  PhD Matej Sova   178 
58. BI-FR/23-24-PROTEUS-002  Development of effective reactivators of organophosphate-inhibited butyrylcholinesterase  1/1/2023 - 12/31/2024  PhD Damijan Knez   276 
59. BI-AT/23-24-008  Development of Hsp90 C-terminal domain inhibitors for the treatment of pediatric sarcomas  1/1/2023 - 12/31/2024  PhD Tihomir Tomašić   445 
60. BI-DE/23-24-009  New mitochondrial ion channels Kv1.3 inhibitors as inducers of apoptosis  1/1/2023 - 12/31/2024  PhD Lucija Peterlin Mašič   442 
61. BI-ME/23-24-030  Non-Alcoholic Fatty Liver Disease in adolescents and its association with oxidative stress, inflammation and genetic factors  1/1/2023 - 12/31/2024  PhD Barbara Ostanek   212 
62. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour  10/1/2021 - 12/31/2024  PhD Alja Štern   5,241 
63. Z1-4405  Development of new antibiotics simultaneously targeting beta-lactamases and penicillin-binding proteins  10/1/2022 - 9/30/2024  PhD Alen Krajnc   39 
64. J1-3021  A synthetic biofilm-based platform for studying and development of new antibiofilm strategies  10/1/2021 - 9/30/2024  PhD Iztok Dogša   1,572 
65. J4-3092  Development of biologically active and chemically stable xanthophylls based on a sustainable esterification of xanthophylls from renewable natural resources  10/1/2021 - 9/30/2024  PhD Alen Albreht   1,515 
66. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration  10/1/2021 - 9/30/2024  PhD Iztok Grabnar   3,292 
67. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile  10/1/2021 - 9/30/2024  PhD Borut Štrukelj   3,451 
68. J1-3018  Smart probes for ex vivo assay-based early prediction of Alzheimer disease  10/1/2021 - 9/30/2024  PhD Janez Košmrlj   2,496 
69. L3-3176  The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID- 19 Disease  10/1/2021 - 9/30/2024  PhD Janja Zupan   3,729 
70. BI-US/22-24-182  Characterization of NOD2 receptor ligand binding  7/1/2022 - 6/30/2024  PhD Žiga Jakopin   223 
71. BI-US/22-24-004  Optimization of selective butyrylcholine esterase inhibitors as potential therapeutic agents for heroin abuse therapy  7/1/2022 - 6/30/2024  PhD Damijan Knez   276 
72. N1-0172  Fotokemijski pristop za odkrivanje naprednih ATP-kompetitivnih prob z zaviralnim delovanjem na Topoizomerazo IIalfa (Slovene)  1/1/2021 - 12/31/2023  PhD Janez Ilaš   851 
73. N1-0169  Kovalentni pristop k boju proti bakterijski rezistenci (Slovene)  1/1/2021 - 12/31/2023  PhD Stanislav Gobec   1,369 
74. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants  9/1/2020 - 12/31/2023  PhD Žiga Jakopin   2,521 
75. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis  9/1/2020 - 8/31/2023  PhD Stanislav Gobec   4,259 
76. J7-2603  EFFICACY OF BACTERIOPHAGES FOR TREATEMENT OF EXTRACELULAR AND INTRACELULAR BACTERIAL INFECTIONS OF IMPLANTANTS  9/1/2020 - 8/31/2023  PhD Aleš Podgornik   2,504 
77. J3-2521  Inflammatory process in interstitial cystitis and evaluation of the influence of cannabinoid receptor agonists in urinary bladder - from cells to patients  9/1/2020 - 8/31/2023  PhD Peter Veranič   4,176 
78. J1-2483  Radiopharmaceuticals with antagonistic activity on CCK2R  9/1/2020 - 8/31/2023  PhD Marko Anderluh   1,198 
79. J3-2518  Role of APOBEC proteins in the oncogenesis of HPV viruses  9/1/2020 - 8/31/2023  PhD Martina Bergant Marušič   1,354 
80. J1-2485  The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs  9/1/2020 - 8/31/2023  PhD Izidor Sosič   1,142 
81. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity  7/1/2019 - 6/30/2023  PhD Tihomir Tomašić   2,112 
82. J3-1745  Elucidating the role of immunoproteasome in platelet-driven immune response  7/1/2019 - 6/30/2023  PhD Martina Gobec   1,286 
83. J3-1749  Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system  7/1/2019 - 6/30/2023  PhD Janja Zupan   2,604 
84. J1-1709  Strukturni vpogled v mehanizem tvorbe površine bakterije Clostridium difficile  7/1/2019 - 6/30/2023  PhD Dušan Turk   2,128 
85. J4-1778  Exploitation of a virus-borne small protein to combat antibiotic resistance in Staphylococcus aureus  7/1/2019 - 12/31/2022  PhD Matej Butala   3,702 
86. N1-0098  Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity  1/1/2019 - 12/31/2022  PhD Lucija Peterlin Mašič   1,003 
87. V4-2038  DNA vaccine and peptide inhibitors against SARS-CoV-2  10/1/2020 - 9/30/2022  PhD Roman Jerala   8,827 
88. Z1-2635  Modular asymmetric total synthesis of bioactive multi-chiral natural products  9/1/2020 - 8/31/2022  PhD Andrej Emanuel Cotman   84 
89. J3-1759  Comprehensive characterization of GWAS hits – pipeline to novel drug targets for anabolic treatment of osteoporosis (GWASforAna)  7/1/2019 - 6/30/2022  PhD Janja Marc   5,311 
90. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F  7/1/2019 - 6/30/2022  PhD Janko Kos   3,366 
91. J1-1715  Protein interaction atlas for prediction of genetic variations involved in drug interactions and disease development  7/1/2019 - 6/30/2022  PhD Dušanka Janežič   2,847 
92. J4-1767  Selective extraction of high value molecules from forest products processing residues in the speciality chemicals sector  7/1/2019 - 6/30/2022  PhD Andreja Kutnar   4,467 
93. J3-9256  Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants  7/1/2018 - 6/30/2022  PhD Žiga Jakopin   3,136 
94. J1-9194  Nanomedicines with antibiotics and probiotics for local treatment of periodontal disease  7/1/2018 - 6/30/2022  PhD Julijana Kristl   3,820 
95. Z1-1859  Targeted covalent inhibitors: inhibiting monoamine oxidase through non-catalytic amino-acid residues  7/1/2019 - 6/30/2021  PhD Damijan Knez   276 
96. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   7/1/2018 - 6/30/2021  PhD Anja Pišlar   3,045 
97. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   7/1/2018 - 6/30/2021  PhD Lucija Peterlin Mašič   2,497 
98. J4-9327  Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria  7/1/2018 - 6/30/2021  PhD Aleš Berlec   2,689 
99. NC-0009  Development of new carbamate-based imaging probes for cholinesterases  4/1/2019 - 3/31/2021  PhD Stanislav Gobec   1,173 
100. V1-1914  Izbor in priprava dosjeja potencialno nevrotoksične kemikalije z uporabo in-silico metod za namen izvajanja evropske kemijske zakonodaje REACH (Slovene)  11/1/2019 - 10/31/2020  PhD Marjan Vračko - Grobelšek   982 
101. N1-0068  Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods  11/1/2017 - 10/31/2020  PhD Stanislav Gobec   2,092 
102. Z1-9195  Butyrylcholinesterase inhibitors for alleviating symptoms of Alzheimer's disease  7/1/2018 - 6/30/2020  PhD Urban Košak   75 
103. NC-0004  NOBIL - Novel Biomarkers in Leukemia  5/1/2018 - 4/30/2020  PhD Irena Mlinarič Raščan   876 
104. J1-8145  Dinamični vidik vezave ligandov na proteine (Slovene)  5/1/2017 - 4/30/2020  PhD Simona Golič Grdadolnik   1,983 
105. J1-8140  Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene)  5/1/2017 - 4/30/2020  PhD Metka Filipič   4,141 
106. J1-8152  Inhibicija prenove celične stene Staphylococus aureus (Slovene)  5/1/2017 - 4/30/2020  PhD Dušan Turk   2,218 
107. J3-8207  Novi izzivi folatne terapije v porodništvu in ginekologiji (Slovene)  5/1/2017 - 4/30/2020  PhD Ksenija Geršak   5,292 
108. J3-8210  Potencial nizkih, sub-terapevtskih odmerkov statinov in sartanov v primarni in sekundarni preventivi src?no-z?ilnih bolezni (Slovene)  5/1/2017 - 4/30/2020  PhD Mirza Šabovič   2,621 
109. J4-8227  Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene)  5/1/2017 - 4/30/2020  PhD Janko Kos   5,178 
110. L1-8157  Razvoj multifunkcionalnih učinkovin za zdravljenje Alzheimerjeve bolezni (Slovene)  5/1/2017 - 4/30/2020  PhD Stanislav Gobec   5,089 
111. V4-1605  The use of hop products for organic control of varroa (Varroa destructor)  10/1/2016 - 9/30/2019  PhD Iztok Jože Košir   3,314 
112. Z1-8158  Discovery of new inhibitors of bacterial peptidoglycan biosynthesis enzymes MurA and MurB  5/1/2017 - 4/30/2019  PhD Marko Jukič   208 
113. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system  3/1/2016 - 2/28/2019  PhD Igor Emri   4,764 
114. J4-7640  Electrostatic immobilisation of bacterial cells and effects on their physiology  3/1/2016 - 2/28/2019  PhD Aleš Lapanje   7,640 
115. J3-7245  Identification of new expression regulators of RANKL, a key molecule not only in bone remodelling  1/1/2016 - 12/31/2018  PhD Janja Marc   2,890 
116. J1-7302  Nanotheranostics based on magneto-responsive materials  1/1/2016 - 12/31/2018  PhD Petra Kocbek   4,347 
117. J1-7515  Receptors for toxins of plant pathogens  1/1/2016 - 12/31/2018  PhD Gregor Anderluh   4,162 
118. J1-7479  Structural insight into iodine metabolism  1/1/2016 - 12/31/2018  PhD Dušan Turk   1,978 
119. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments  1/1/2016 - 12/31/2018  PhD Mateja Erdani Kreft   7,742 
120. V3-1636  Sistem odkrivanja novih psihoaktivnih snovi v Sloveniji (akronim SONDA) (Slovene)  10/1/2016 - 9/30/2018  PhD Miran Brvar   1,600 
121. Z1-7181  Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer  1/1/2016 - 12/31/2017  PhD Izidor Sosič   299 
122. L1-6745  Boj proti bakterijski rezistenci: optimizacija zaviralcev biosinteze bakterijske stene (Slovene)  7/1/2014 - 6/30/2017  PhD Stanislav Gobec   3,575 
123. J1-6746  Nanozdravila za zdravljenje parodontalne bolezni s ciljanim vnosom v obzobne žepe (Slovene)  7/1/2014 - 6/30/2017  PhD Julijana Kristl   4,225 
124. J1-6744  Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bio-analitike (Slovene)  7/1/2014 - 6/30/2017  PhD Tina Kosjek   5,370 
125. J1-6743  Razvoj računalniških orodij za modeliranje farmacevtsko zanimivih molekul (Slovene)  7/1/2014 - 6/30/2017  PhD Dušanka Janežič   3,028 
126. J3-6792  TRANS TIO Translacijske farmakogenomske raziskave tiopurinske terapije (Slovene)  7/1/2014 - 6/30/2017  PhD Irena Mlinarič Raščan   1,762 
127. J4-6811  Vloga inhibitorjev cisteinskih proteaz v citotoksičnem delovanju naravnih celic ubijalk na tumorske celice (Slovene)  7/1/2014 - 6/30/2017  PhD Janko Kos   2,839 
128. J3-5507  ANALIZA BIOLOŠKIH OZNAČEVALCEV PRESNOVE FOLATOV PRI UGOTAVLJANJU TVEGANJA ZA NASTANEK NAPAK NEVRALNE CEVI (Slovene)  8/1/2013 - 7/31/2016  PhD Ksenija Geršak   3,878 
129. J3-5511  Mikro RNA - nove diagnostične in terapevtske tarče pri osteoporozi (Slovene)  8/1/2013 - 7/31/2016  PhD Janez Preželj   1,825 
130. J3-5502  Napake v regulaciji izražanja TDP-43 pri amiotrofični lateralni sklerozi in frontotemporlani lobarni degeneraciji (Slovene)  8/1/2013 - 7/31/2016  PhD Boris Rogelj   5,672 
131. J4-5529  Nitroksolin in njegovi derivati kot nova protitumorska zdravila (Slovene)  8/1/2013 - 7/31/2016  PhD Janko Kos   6,653 
132. J1-5450  Proteinsko načrtovanje rekombinantnih probiotičnih mlečnokislinskih bakterij za zdravljenje sindromov vnetega črevesa (Slovene)  8/1/2013 - 7/31/2016  PhD Borut Štrukelj   2,628 
133. Z1-5458  Design, synthesis, and evaluation of new voltage-gated sodium channels modulators  8/1/2013 - 7/31/2015  PhD Nace Zidar   265 
134. J4-4123  Inhibitorji cisteinskih karboksipeptidaz kot regulatorji avtoimunskih in nevrodegenerativnih procesov (Slovene)  7/1/2011 - 6/30/2014  PhD Janko Kos   6,996 
135. L2-4072  Kompleksni hiperspektralni sistem za avtomatsko analiziranje in vodenje procesov oblaganja farmacevtskih pelet (Slovene)  7/1/2011 - 6/30/2014  PhD Boštjan Likar   2,387 
136. J1-4236  Načrtovanje, izdelava in vrednotenje biomimetičnih nanokompozitnih sistemov za učinkovito obnovo tkiv (Slovene)  7/1/2011 - 6/30/2014  PhD Julijana Kristl   5,338 
137. L1-4039  Predklinični razvoj novih protimikrobnih učinkovin (Slovene)  7/1/2011 - 6/30/2014  PhD Stanislav Gobec   4,594 
138. J3-4285  Razvoj in ovrednotenje radiooznačenih bioloških molekul za ciljano radionuklidno terapijo nevroendokrinih tumorjev in spremljajočo diagnostiko (Slovene)  7/1/2011 - 6/30/2014  PhD Jurij Fettich   2,500 
139. L6-4045  Teoretični in praktični vidiki terminologije in terminografije v povezavi s spletnimi terminološkimi viri (Slovene)  7/1/2011 - 6/30/2014  PhD Andreja Žele   4,312 
140. J3-4026  Transport in RNA vezava proteinov TDP-43 in FUS - implikacije za ALS/FTLD spekter nevrodegenerativnih bolezni (Slovene)  7/1/2011 - 6/30/2014  PhD Boris Rogelj   5,034 
141. J3-4220  Vloga genetskih polimorfizmov na izid zdravljenja in pojav zapletov pri otrocih z rakom (Slovene)  7/1/2011 - 6/30/2014  PhD Janez Jazbec   3,716 
142. J3-4313  Vpliv aktivnega transporta imatiniba in različnih genotipov pacientov na uspešnost terapije kronične mieloične levkemije (Slovene)  7/1/2011 - 6/30/2014  PhD Albin Kristl   3,353 
143. J3-3615  Farmakogenetski pristop k raziskavam, diagnostiki in terapiji levkemij (Slovene)  5/1/2010 - 4/30/2013  PhD Irena Mlinarič Raščan   2,329 
144. J3-2330  Genetski dejavniki pri osteoporozi (Slovene)  5/1/2009 - 4/30/2012  PhD Janja Marc   2,533 
145. J4-2212  Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene)  5/1/2009 - 4/30/2012  PhD Nada Kraševec   3,961 
146. J3-2356  Izrazanje in funkcionalna analiza nekodirajocih RNA pri parkinsonovi bolezni (Slovene)  5/1/2009 - 4/30/2012  PhD Boris Rogelj   4,695 
147. L3-2293  Zaščitni pleiotropni učinki nizkih odmerkov zaviralcev sistema renin-angiotenzin in statinov pri zdravi populaciji srednjih let (Slovene)  5/1/2009 - 4/30/2012  PhD Mirza Šabovič   4,020 
148. J3-0488  FUNKCIONALNA ANALIZA NEKODIRAJOČIH RNA PRI PARKINSONOVI BOLEZNI (Slovene)  2/1/2008 - 1/31/2011  PhD Boris Rogelj   2,483 
149. L3-0431  GENETIKA RAKA DOJK IN HORMOSNKO NADOMESTNO ZDRAVLJENJE (Slovene)  2/1/2008 - 1/31/2011  PhD Ksenija Geršak   3,938 
150. L3-0129  IZVENCELIČNE NUKLEINSKE KISLINE V DIAGNOSTIKI KORONARNE ATEROSKLEROZE (Slovene)  2/1/2008 - 1/31/2011  PhD Darko Černe   2,135 
151. L4-1046  Nove zdravilne učinkovine biotehnološkega izvora z uporabo bakteriofagnega prikaza (Slovene)  2/1/2008 - 1/31/2011  PhD Borut Štrukelj   4,375 
152. L3-0636  PRIPRAVA IN EVALVACIJA STABILIZIRANE KONTROLNE KRVI ZA HEMOGRAM IN DIFERENCIALNO BELO KRVNO SLIKO ZA HEMATOLOŠKE ANALIZATORJE ZA POTREB (Slovene)  2/1/2008 - 1/31/2011  PhD Milan Skitek   1,183 
153. L6-0075  Slovenska terminologija v povezavi s spletnimi jezikovnimi viri (Slovene)  2/1/2008 - 1/31/2011  PhD Andreja Žele   3,068 
154. J7-0337  Formulation and characterization of fuzogenic colloidal nanoparticles for efficient drug delivery into cells  2/1/2008 - 1/30/2011  PhD Marjeta Šentjurc   1,679 
155. J7-0474  New Report on Condition of Knowledge in Developed Societies – 30 Years after Jean-François Lyotard’s Analysisew Report on Knowledge  2/1/2008 - 1/30/2011  PhD Mladen Dolar   3,277 
156. J1-0957  Pharmacogenetic study of raloxifene metabolism and transport  2/1/2008 - 1/30/2011  PhD Aleš Mrhar   2,068 
157. J7-9704  NQR - nondestructive method for studying of polymorphism in heteregeneous pharmaceutical systems  7/1/2007 - 6/30/2010  PhD Zvonko Trontelj   4,823 
158. J4-9425  Lektini kot modulatorji protitumorskega imunskega odziva (Slovene)  1/1/2007 - 12/31/2009  PhD Janko Kos   2,388 
159. J4-7062  Proteomics as a tool for monitoring biosynthesis processes  9/1/2005 - 8/31/2008  PhD Janko Kos   6,270 
160. J1-7363  Role of the proteolytic systems in the malignancy of brain tumour stem cells.  9/1/2005 - 8/31/2008  PhD Irena Zajc   3,615 
161. J3-7406  Thiopurine pharmacogenetics - novel diagnostics and individualized therapy   9/1/2005 - 8/31/2008  PhD Irena Mlinarič Raščan   2,763 
162. M4-0124  Prehranski dodatki za optimalno prehrano v ekstremnih razmerah (Slovene)  6/1/2006 - 11/30/2007  PhD Samo Kreft   4,229 
163. J3-6429  Genetski dejavniki reproduktivnega zdravja ženske (Slovene)  7/1/2004 - 6/30/2007  PhD Ksenija Geršak   3,546 
164. J1-6356  Use of inorganic particles for particle design and their potential application in systems with modified release  7/1/2004 - 6/30/2007  PhD Marjan Bele   2,836 
165. L1-6707  Design, synthesis and test of potencial hypolipidemic drugs with a new target  2/1/2004 - 1/30/2007  PhD Uroš Urleb   3,628 
166. L1-6711  Development of a technological procedure for preparation of biologicaly active hop extract enriched with xanthohumol  7/1/2004 - 6/30/2006  PhD Tamara Lah Turnšek   6,276 
167. Z1-6451  Mehanizem povečanja permeabilnosti sečnega mehurja s hitosanom (Slovene)  7/1/2004 - 6/30/2006  PhD Danijel Kikelj   861 
168. Z4-6096  Peptide ligands as novel biopharmaceutics by using phage display technology  2/1/2004 - 1/30/2006  PhD Borut Štrukelj   1,397 
169. L1-5267  Analysis of gene expression associated with apoptosis using microarrays  1/1/2003 - 12/31/2005  PhD Irena Mlinarič Raščan   770 
170. L3-5309  Analysis of gene expression associated with apoptosis using microarrays  1/1/2003 - 12/31/2005  PhD Irena Mlinarič Raščan   1,197 
171. L1-5094  Determination of surface properties of solid and semisolid materials by solid and semisolid materials with inverse phase gas chromatography  1/1/2003 - 12/31/2005  PhD Stanko Srčič   2,941 
172. L3-5084  Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)  1/1/2003 - 12/31/2005  PhD Mojca Stegnar   5,845 
173. L4-4090  Optimizacija kakovosti zdravilnih rastlin (Echinacea purpurea Moench., Gentiana lutea L., Hypericum perforatum L.) v pridelovanju (Slovene)  7/1/2002 - 6/30/2005  PhD Dea Baričevič   2,515 
174. Z1-3238  Genetic and environmental risk factors for bone remodelation disturbances  7/1/2001 - 6/30/2004  PhD Samo Kreft   2,156 
175. J3-3395  Genetic causes of female infertility 2   7/1/2001 - 6/30/2004  PhD Ksenija Geršak   4,820 
176. J3-3314  Genetic factors and hormones in metabolic diseases  7/1/2001 - 6/30/2004  PhD Andreja Kocijančič   5,139 
177. L1-3261  Development of biologicaly active peptidomimetics  7/1/2001 - 12/31/2003  PhD Uroš Urleb   2,145 
178. V4-0476  Ekotoksikološki, rezidualni in ekonomski vidiki uporabe avermektinskih zdravil pri drobnici (Slovene)  1/1/2002 - 10/31/2003  PhD Vesna Cerkvenik Flajs   5,013 
179. L1-2129  Raziskave uporabnost proste površinske energije pri trdnih farmacevtskih sistemih (Slovene)  1/1/2000 - 6/30/2002  PhD Franc Vrečer   2,393 
180. L3-2003  Razvoj rutinskih metod za dolocanje presnovkov galaktoze in genotipizacijo galaktozemij (Slovene)  1/1/2000 - 6/30/2002  PhD Tadej Battelino   3,249 
181. L1-1381  Biofarmacevtske lastnosti, sinteza in aktivnost spojin kinolonov s kovinskimi atomi (Slovene)  1/1/1999 - 6/30/2001  PhD Albin Kristl   5,237 
182. L4-1301  Proučevanje aktualnih kužnih bolezni pri živalih z uporabo sodobnih imunoloških, biokemijskih in molekularnih metod (Slovene)  1/1/1999 - 6/30/2001  PhD Darja Barlič Maganja   9,193 
183. J2-1537  Reološke lastnosti in ostali transportni procesi hidrofilnih polimerov (Slovene)  1/1/1999 - 6/30/2001  PhD Miha Žumer   3,274 
184. J1-0572  Interakcije bioaktivnih ligandov v sistemih rastoče kompleksnosti (Slovene)  7/1/1998 - 6/30/2001  PhD Aleš Mrhar   5,742 
185. L4-0827  Tkivne kulture za proizvodnjo sekundarnih metabolitov (Slovene)  7/1/1998 - 6/30/2001  PhD Jana Žel   3,220 
186. J1-7377  Protivirusne spojine: transport in interakcije v biosistemih (Slovene)  1/1/1996 - 6/30/2001  PhD Albin Kristl   2,740 
187. J3-7880  Ugotavljanje biokemičnih in elektrofizioloških parametrov pri kronično bolnih otrocih in mladostnikih (Slovene)  1/1/1996 - 6/30/2001  PhD Ciril Kržišnik   6,003 
188. V4-9128  Uporaba rastlinske biotehnologije za varstvo rastlin (razvoj identifikacijskih metod za rastlinske patogene in ovrednotenje transgenih (Slovene)  10/1/1997 - 9/30/2000  PhD Maja Ravnikar   6,690 
189. L1-0469  Optimization of MDP and TNF analogues having therapeutic potential  7/1/1998 - 6/30/2000  PhD Anton Štalc   6,609 
190. J1-8889  Mimetics of biologically active peptides: Strategies of design and synthesis  1/1/1997 - 12/31/1999  PhD Danijel Kikelj   4,011 
191. J1-8891  Synthesis, identification, and properties of potential pharmaceuticals  1/1/1997 - 12/31/1999  PhD Andrej Petrič   1,911 
192. L1-8890  Raziskave hidrodinamsko uravnoteženih farmacevtskih oblik z nadzorovanim sproščanjem (Slovene)  1/1/1997 - 12/31/1998  PhD Franc Vrečer   2,018 
193. L4-7355  Alternativno koriščenje za slovenijo perspektivnih zdravilnih in aromatičnih rastlin in njihovo vrednotenje (Slovene)  1/1/1996 - 12/31/1998  PhD Dea Baričevič   1,701 
194. L1-7823  Lastnosti in sinteza organokovinskih spojin z biološko učinkovitostjo (Slovene)  1/1/1996 - 12/31/1998  PhD Stanislav Primožič   6,833 
195. L2-7632  Spektralno selektivne energetsko efektne prevleke za solarne namene (Slovene)  1/1/1996 - 12/31/1998  PhD Boris Orel   2,499 
196. L1-7379  Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene)  1/1/1996 - 6/30/1998  PhD Anton Štalc   6,340 
197. J1-7053  Selektivni ligandi: sinteza, interakcije z makromolekulami in transport v biosistemih (Slovene)  1/1/1995 - 6/30/1998  PhD Aleš Mrhar   7,232 
198. J3-7200  Uporabnost kvalitativne metode za vrednotenje bolnikovega jemanja zdravil (Slovene)  1/1/1995 - 6/30/1998  PhD Jelka Šmid-Korbar   567 
ARIS research and infrastructure programmes (26) Legend
no. Code Title Period Responsible person No. of publications
1. P1-0420  Advanced immunological drugs and cell-based approaches in pharmacy  1/1/2022 - 12/31/2027  PhD Žiga Jakopin   1,465 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation  1/1/2022 - 12/31/2027  PhD Stanislav Gobec   6,006 
3. P3-0314  Systemic Autoimmune diseases  1/1/2022 - 12/31/2027  PhD Katja Lakota   5,865 
4. I0-0022  The Infrastructure Program of University of Ljubljana »Network of Research and Infrastructural Centers UL (MRIC UL)«  1/1/2022 - 12/31/2027  PhD Gregor Dolinar   8,608 
5. P3-0298  Genes, hormones and personality changes in metabolic disorders  1/1/2019 - 12/31/2027  PhD Andrej Janež   3,950 
6. P4-0127  Pharmaceutical biotechnology: Science for health  1/1/2019 - 12/31/2027  PhD Anja Pišlar   5,817 
7. P1-0189  Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly  1/1/2018 - 12/31/2027  PhD Mitja Kos   7,380 
8. I0-E011  EATRIS  1/1/2025 - 12/31/2025  PhD Irena Mlinarič Raščan   1,914 
9. I0-E011  EATRIS  1/1/2024 - 12/31/2024  PhD Irena Mlinarič Raščan   2,112 
10. I0-E011  Sofinanciranje izvajanja mednarodnega infrastrukturnega projekta (Slovene)  1/1/2023 - 12/31/2023  PhD Irena Mlinarič Raščan   1,927 
11. I0-E011  Sofinanciranje izvajanja mednarodnega infrastrukturnega projekta EATRIS (Slovene)  1/1/2022 - 12/31/2022  PhD Irena Mlinarič Raščan   2,029 
12. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation  1/1/2015 - 12/31/2021  PhD Stanislav Gobec   6,708 
13. I0-0022  Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL) (Slovene)  1/1/2015 - 12/31/2021  PhD Anton Ramšak   14,714 
14. P3-0298  Genes, hormones and personality changes in metabolic disorders  1/1/2015 - 12/31/2018  PhD Andrej Janež   5,249 
15. P4-0127  Pharmaceutical biotechnology: Science for Health  1/1/2015 - 12/31/2018  PhD Janko Kos   5,474 
16. P1-0189  Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly  1/1/2014 - 12/31/2017  PhD Albin Kristl   7,277 
17. P3-0298  Genes, hormones and personality changes in metabolic disorders  1/1/2009 - 12/31/2014  PhD Janez Preželj   4,946 
18. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation  1/1/2009 - 12/31/2014  PhD Danijel Kikelj   6,574 
19. P4-0127  Pharmaceutical biotechnology: Knowledge for Health  1/1/2009 - 12/31/2014  PhD Janko Kos   5,996 
20. P1-0189  Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih (Slovene)  1/1/2009 - 12/31/2013  PhD Aleš Mrhar   7,377 
21. P3-0298  Genes, hormones and personality changes in metabolic disorders  7/1/2004 - 12/31/2008  PhD Janez Preželj   4,085 
22. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation  1/1/2004 - 12/31/2008  PhD Danijel Kikelj   6,579 
23. P4-0127  Pharmaceutical biotechnology: Knowledge for Health  1/1/2004 - 12/31/2008  PhD Janko Kos   5,778 
24. P1-0189  Pharmaceutical technology: design, preparation and evaluation of drug delivery systems  1/1/2004 - 12/31/2008  PhD Aleš Mrhar   7,317 
25. P0-0502-0787  Farmacevtska kemija (Slovene)  1/1/1999 - 12/31/2003  PhD Danijel Kikelj   7,935 
26. P0-0501-0787  Farmacevtska tehnologija (Slovene)  1/1/1999 - 12/31/2003  PhD Aleš Mrhar   5,894 
International projects (63) source: SICRIS
no. Code Title Period Responsible person
1. HORIZON-PARC-101057014  Partnership for the Assessment of Risks from Chemicals  5/1/2022 - 4/30/2029   
2. HORIZON-SIMPATHIC-101080249  Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology  7/1/2023 - 6/30/2028   
3. HORIZON-GlyCanDrug-101119601  A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer  12/1/2023 - 11/30/2027  PhD Marko Anderluh  
4. HORIZON-BREAKthrough-101072632  Breaking the barrier - An integrated multidisciplinary approach to kill Gram-negative bacteria through existing antibiotics by making their outer membrane permeable  1/1/2023 - 9/30/2027  PhD Stanislav Gobec  
5. HORIZON-EATRIS-CONNECT-101130349  EATRIS-CONNECT  5/1/2024 - 4/30/2027  PhD Irena Mlinarič Raščan  
6. COST-HAPLO-iPS-CA21151    10/11/2022 - 10/10/2026   
7. COST-ADVANCE-TB-CA21164    9/29/2022 - 9/28/2026   
8. COST-EURESTOP-CA21145    10/6/2022 - 10/5/2025   
9. CELSA/23/038  Degradation of CDK1 and HDACs as a strategy to treat T-cell malignancies  10/1/2023 - 9/30/2025   
10. CELSA/23/031  Exploiting structural insights in IP3 receptor function to develop novel, allosteric inhibitors of IP3 receptor channels (SINFONIC)  10/1/2023 - 9/30/2025   
11. ERASMUS+-DOMINOS    1/1/2022 - 12/31/2024  PhD Mitja Kos  
12. HORIZON-HORIZON-HLTH-2021-ENWHLTH-03-01  PARC - osnutek  12/2/2024 - 12/2/2024   
13. COST-CA19132 ENABLE    10/20/2020 - 10/19/2024   
14. CELSA/22/026  The role of snoRNAs in the etiology of inflammatory bowel disease  10/1/2022 - 9/30/2024   
15. HORIZON-HUMANITIES ROCK-101060963  Humanities Rock! Human(e) to Animals – Science Covers Every Being!  4/11/2022 - 12/10/2023  PhD Sašo Jerše  
16. COST-CA18103 - INNOGLY    11/13/2018 - 10/7/2023   
17. COST-CA18132 GLYCONanoPROBES  Functional Glyconanomaterials for the Development of Diagnostics and Targeted Therapeutic Probes  1/1/2018 - 9/13/2023  PhD Marko Anderluh  
18. ERASMUS+-EATRIS ADVANCE-2019-1-NL01-KA203-060286  ADVANCE - Educating the next generation of Advanced Therapy (ATMP) professionals and advancing ATMP development  11/1/2019 - 12/31/2022   
19. COST-CA17117 EVBRES  Genomics of musculoskeletal traits translational network  1/1/2018 - 12/31/2022  PhD Janja Marc  
20. COST-CA18139 GEMSTONE  Genomics of musculoskeletal traits translational network  1/1/2018 - 12/31/2022  PhD Janja Marc  
21. COST-CA17118  Identifying biomarkers through translational research for prevention and stratification of colorectal cancer  1/1/2018 - 12/31/2022  PhD Marija Sollner Dolenc  
22. COST-CA17104  New diagnostic and therapeutic tools against multidrug resistant tumors  1/1/2018 - 12/31/2022  PhD Nace Zidar  
23. Crossborder cooperation-ARTE  Advanced Regenerative Therapies Ecosystem  1/1/2017 - 12/31/2022  PhD Tilen Kranjc  
24. CELSA - Cental Europe Leuven Strategic Alliance-Generiranje nanoteles...  Generation of nanobodies against immunomodulating checkpoint receptors in glioblastoma tumor cells  10/1/2020 - 9/30/2022  PhD Ivana Jovchevska  
25. ESRR-LAKTIKA - C3330-18-952002  LAKTIKA-fractionation and processing of whey proteins and exploitation of the residue for the formulation of new functional foods and food supplements  7/1/2018 - 12/31/2021   
26. H2020-PhD4GlycoDrug-211719  Multidisciplinary European Joint Doctorate in the Design and Developmen of Glyco Drugs  1/1/2017 - 12/31/2021  PhD Marko Anderluh  
27. COST-CA16231  European Network of Vaccine Adjuvants  11/13/2017 - 11/12/2021  PhD Žiga Jakopin  
28. COST-CA16205  European Network on Understanding Gastrointestinal Absorption-related Processes  10/24/2017 - 10/23/2021  PhD Albin Kristl  
29. COST-CA16225  Realising the therapeutic potential of novel cardioprotective therapies  10/19/2017 - 10/18/2021  PhD Nace Zidar  
30. WADA - World anti-doping Agency-2017  Reliable assay for rapid detection of potentially unknown erythropoietin mimetics chemically unrelated to endogenous hormone in biological samples  1/1/2018 - 12/31/2020  PhD Borut Štrukelj  
31. INTERREG-ARTE    10/1/2017 - 12/31/2020   
32. COST-CA15138  European Network of Multidisciplinary Research and Translation of Autophagy knowledge (TRANSAUTOPHAGY)  4/22/2016 - 4/21/2020  PhD Žiga Jakopin  
33. COST-CA15135  Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)  4/18/2016 - 4/17/2020   
34. The Foundation for Prader-Willi Research-2018  A transcriptome-wide approach to identifying RNA targets of the Prader-Willi locus snornas  1/1/2018 - 12/31/2019  PhD Tomaž Bratkovič  
35. COST-MP1404  Simulation and pharmaceutical technologies for advanced patient-tailored inhaled medicines (SimInhale)  5/4/2015 - 5/3/2019  PhD Stanko Srčič  
36. COST-BM1406  Ion Channels and Immune Response toward a global understanding of immune cell physiology and for new therapeutic approaches (IONCHAN-IMMUNRESPON)  3/31/2015 - 3/30/2019  PhD Nace Zidar  
37. COST-CM1406  Epigenetic Chemical Biology (EPICHEM)  3/24/2015 - 3/23/2019   
38. COST-CM1407  Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery   3/16/2015 - 3/15/2019   
39. CELSA - Cental Europe Leuven Strategic Alliance-Discovery  Discovery of new leads modulating voltage gated potassium ion channels as emerging cancer targets  1/1/2017 - 12/31/2018  PhD Lucija Peterlin Mašič  
40. H2020-EU.1.3.1-INTEGRATE-193930  Interdisciplinary Training Network for Validation of Gram-Negative Antibacterial Targets  1/1/2015 - 12/31/2018  PhD Danijel Kikelj  
41. COST-CM1307  Targeted chemotherapy towards diseases caused by endoparasites  3/12/2014 - 3/11/2018   
42. COST-MP1206  Electrospun nano-fibres for bio inspired composite materials and innovative industrial applications  5/23/2013 - 5/22/2017   
43. LIFE+-PharmDegrade  Degradation of pharmaceuticals in wastewaters from nursing homes and hospitals  1/1/2014 - 12/31/2016  PhD Albin Kristl  
44. LLP-EACEA-543516  Higher education Online: MOOCs the European Way  1/1/2013 - 12/31/2016  PhD Julijana Kristl  
45. COST-CM1201  Biomimetic Radical Chemistry  12/6/2012 - 12/5/2016  PhD Marija Sollner Dolenc  
46. H2020-EU.4.a-ARTEMIDA-197116  Advanced Regional Translation of Excellence into Medical Innovations for Delayed Aging  6/1/2015 - 5/31/2016   
47. COST-CM1106  Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells  3/28/2012 - 3/27/2016  PhD Danijel Kikelj  
48. LLP-LIAT-Pharma  Linking Industry and Academia inTeaching Pharmaceutical Developmentand Manufacture  1/1/2013 - 12/31/2015  PhD Stanko Srčič  
49. LLP-PHAR-QA  Quality Assessment of Pharmaceutical education and training (PET) in Europe  1/1/2012 - 12/31/2015  PhD Borut Božič  
50. LLP-EACEA-527194  Quality assurance in pharmacy education and training in Europe  1/1/2012 - 12/31/2015   
51. FP7-HEALTH-ORCHID-96802  Open Collaborative Model for Tuberculosis Lead Optimisation  1/1/2011 - 6/30/2015  PhD Stanislav Gobec  
52. ESS-PR12168  Nova generacija raziskovalcev ved o življenju št. OP13.2.3.1.51  1/1/2012 - 12/31/2014   
53. ESS-NGRVŽ  Znanje za prihodnost - Nova generacija raziskovalcev ved o življenju št. OP13.2.2.1.51  1/1/2012 - 12/31/2014  PhD Tomaž Bratkovič  
54. FP7-KBBE-95006  Exploring Marine Resources for Bioactive Compounds: From Discovery to Sustainable Production and Industrial Applications  8/1/2010 - 7/31/2014  PhD Danijel Kikelj  
55. COST-TD0905  Epigenetics: Bench to Bedside  6/16/2010 - 6/15/2014   
56. TEMPUS-EACEA-158897  PQPHARM - Postgraduate Qualification in Pharmacy: The way forward  1/1/2010 - 12/31/2013  PhD Stanko Srčič  
57. COST-CM0801  New drugs for neglected diseases  11/28/2008 - 11/27/2012  PhD Lucija Peterlin Mašič  
58. FP7-HEALTH-86689  Targeted Nanosystems for Improving Photodynamic Therapy and Diagnosis of Cancer  7/1/2008 - 12/31/2011  PhD Janko Kos  
59. COST-CM0602  Inhibitors of angiogenesis: design, synthesis and biological exploitation (ANGIOKEM)  6/7/2007 - 6/6/2011  PhD Danijel Kikelj  
60. FP6-LIFESCIHEALTH-EUR-INTAFAR-74098  Inhibition of new targets for fighting antibiotic resistance  1/1/2005 - 6/30/2010  PhD Stanislav Gobec  
61. COST-D34  Molecular Targeting and Drug Design in Neurological and Bacterial Diseases  6/24/2005 - 6/23/2010  PhD Danijel Kikelj  
62. FP6-MOBILITY-GALENOS EURO-PHD-73425  Towards a European PhD in Advanced Drug Delivery  10/1/2004 - 9/30/2008  PhD Julijana Kristl  
63. FP4-INCO-47290  Development of an assay for quantitating residues in meat products  3/1/1999 - 6/30/2002  PhD Slavko Pečar  
Research equipment (40)
no. Equipment name Year of purchase Purchase price (€) Responsible for equipment Classification Source of co-financing
1. 400 MHz NMR spektrometervisoke ločljivosti  2012  218160  PhD Marko Anderluh   Analytical facilities  Programs, projects 
2. ABI PRISM Nucleic Acid PrepStation  2002  80653  PhD Janja Marc   Genomic, transcriptomic, proteomics and metabolomics facilities  Package 11 
3. Agilent 1260 Infinity Quaternary LC  2011  51241  PhD Alenka Šmid   Analytical facilities  Projects, programs and other public resources 
4. Automated high-conent analysis system for phenotypic analysis of cells (Cell painting system)  2024  414410  PhD Dunja Urbančič   Cell culture facilities  22 
5. Automated Platform for Live Cell Imaging  2006  122252  PhD Janko Kos   Cell culture facilities  Package 12 
6. BD FACSCalibur Flow Cytometer  2007  142560  PhD Janko Kos   Cell culture facilities  Package 13 
7. Bio-Layer Interferometry - BLI  2023  170502    Structural biology facilities  21 
8. Chromatographic system ÄKTAexplorer 10 S  2008  82427  PhD Tomaž Bratkovič   Genomic, transcriptomic, proteomics and metabolomics facilities  Projects, programs and other public resources 
9. Confocal laser scanning microscope with four lasers and high-sensitivity GaAsP detectors  2024  511870  PhD Martina Gobec   Cell culture facilities  21 
10. Čitalec mikrotitrskih plošč (Synergy H4) in robot za pipetiranje (Precision XS) Multi-Mode Microplate Reader (SINERGY H4) and robot for automatic pipetting (PRECISION XS)   2010  124979  PhD Martina Hrast Rambaher   Analytical facilities  Programms, projects and/or market surplus 
11. Device of advanced pharmaceutical texture analysis  2024  163358  PhD Alenka Zvonar Pobirk   Analytical facilities  22 
12. Diffusion cells for release and dermal absorption evaluation with an automated sampling system (i.e. Phoenix dry heat system)  2023  129093  PhD Mirjam Gosenca Matjaž   Analytical facilities  21 
13. Flow cytometer Attune NxT   2015  116441  PhD Martina Gobec   Analytical facilities  Programms, projects and/or market surplus 
14. Flow cytometer with four solid state lasers with automatic sampler  2023  203482  PhD Anja Pišlar     21 
15. GenomeLab™ GeXP Genetic Analysis System (Beckman Coulter)  2010  95303  PhD Alenka Šmid   Analytical facilities  Projects, programs and other public resources 
16. High Performance Liquid Chromatograph for Biopharmaceutical and Physico-chemical characterisation  2024  141990  PhD Simon Žakelj   Analytical facilities  22 
17. High shear Granulator 4M8Trix  2012  54845  PhD Rok Dreu   Research facilities  Programms, projects and/or market surplus 
18. HPLC - High performance liquid chromatograph   2021  79682  PhD Dunja Urbančič   Genomic, transcriptomic, proteomics and metabolomics facilities  Projects, programs and other public resources 
19. HPLC Liquid chromatograph   2018  61911  PhD Zoran Lavrič     Programms, projects and/or market surplus 
20. Imaging flow cytometer  2019  454926  PhD Martina Gobec   Analytical facilities  Package 17 
21. Integrirani sistem konfokalnega Ramanskega mikroskopa in mikroskopa na atomsko silo XploRA PLUS-OmegaScope  2020  378021  PhD Zoran Lavrič     Programms, projects and/or market surplus 
22. Laser diffractometer  2019  84220  PhD Ilija German Ilić     Programms, projects and/or market surplus 
23. Leistritz ZSE 12 HP-PH twin screw hot melt extruder for hot melt extrusion (HME) and twin screw granulation (TSG) with supporting equipment for material feed, cooling and processing of extrudates  2020  276861  PhD Zoran Lavrič     Package 17 
24. Liquid Chromatograph  2024  79992  PhD Simon Žakelj   Analytical facilities  22 
25. Mass spectrometer (MS)  2015  96016  PhD Janez Ilaš   Analytical facilities  Programms, projects and/or market surplus 
26. Multimode microtiter plate reader - absorbance, fluorescence, luminescence  2024  75706  PhD Tomaž Bratkovič   Analytical facilities  22 
27. Multistage LC/MS system  2021  345742      Programms, projects and/or market surplus 
28. Pan Coatear GMPC I  2014  76110  PhD Rok Dreu   Research facilities  Projects, programs and other public resources 
29. Photon correlation spectroscopy and laser Doppler electrophoresis (Zetasizer Ultra)  2020  67472  PhD Pegi Ahlin Grabnar   Analytical facilities  Programms, projects and/or market surplus 
30. Preparative chromatography system coupled to a mass detector and ELSD detector  2024  187401  PhD Janez Ilaš   Analytical facilities  22 
31. Reometer - Anton Paar  2011  92557  PhD Saša Baumgartner   Research facilities  Projects, programs and other public resources 
32. SOTAX CE 7 smart DISSOTEST ON/OFF-LINE  2007  100836  PhD Marija Bogataj   Analytical facilities  Package 13 
33. System for electrostatic spinning of nanofibers   2015  102271  PhD Zoran Lavrič   Research facilities  Programms, projects and/or market surplus 
34. Transgenomic WAVE MD dHPLC SISTEM Plus  2007  103320  PhD Janja Marc   Genomic, transcriptomic, proteomics and metabolomics facilities  Package 13 
35. UHPLC-MS/MS Liquid chromatograph coupled to mass detector triple quadrupole/linear ion trap. Agilent 1290 Infinity II / Sciex QTRAP 5500+  2020  281298  PhD Jurij Trontelj     Package 18 
36. UHPLC system coupled to DAD and CAD detector  2020  149852  PhD Stane Pajk     Package 18 
37. UHPLC system coupled to mass detector (UHPLC-MS)  2023  217067    Analytical facilities  21 
38. Ultra centrifuga WX 100, Sorvall (Thermo Fischer scientific)  2011  96037  PhD Petra Kocbek   Research facilities  Projects, programs and other public resources 
39. Ultra high preasure liquid chromatograph with triple quadrupole tandem mass spectrometer (LC/MS/MS) Agilent 6460  2010  376685  PhD Jurij Trontelj   Analytical facilities  Package 14 
40. Večmodularni čitalec mikrotitrskih plošč  2021  137789  PhD Martina Gobec     Projects, programs and other public resources 
Mentors for junior researchers (36)
no. Code Name and surname Research area Status
1. 00035  PhD Dušan Hadži  Chemistry  Researcher 
2. 00831  PhD Jelka Šmid-Korbar  Pharmacy  Researcher 
3. 00839  PhD Aleš Krbavčič  Pharmacy  Researcher 
4. 01463  PhD Danijel Kikelj  Pharmacy  Researcher 
5. 01466  PhD Vojko Kmetec  Pharmacy  Researcher 
6. 01878  PhD Uroš Urleb  Pharmacy  Researcher 
7. 03070  PhD Slavko Pečar  Pharmacy  Researcher 
8. 04648  PhD Janko Kos  Biotechnical sciences  Researcher 
9. 06086  PhD Aleš Mrhar  Pharmacy  Researcher 
10. 07849  PhD Borut Štrukelj  Biochemistry and molecular biology  Researcher 
11. 08519  PhD Marija Sollner Dolenc  Pharmacy  Researcher 
12. 09031  PhD Stanko Srčič  Pharmacy  Researcher 
13. 09032  PhD Julijana Kristl  Pharmacy  Researcher 
14. 09066  PhD Stanislav Primožič  Pharmacy  Researcher 
15. 11122  PhD Albin Kristl  Pharmacy  Researcher 
16. 11124  PhD Marija Bogataj  Pharmacy  Researcher 
17. 11789  PhD Mirjana Gašperlin  Pharmacy  Researcher 
18. 12189  PhD Janja Marc  Metabolic and hormonal disorders  Researcher 
19. 12443  PhD Irena Mlinarič Raščan  Pharmacy  Researcher 
20. 14935  PhD Odon Planinšek  Pharmacy  Researcher 
21. 15284  PhD Stanislav Gobec  Pharmacy  Researcher 
22. 15460  PhD Samo Kreft  Pharmacy  Researcher 
23. 18154  PhD Barbara Ostanek  Metabolic and hormonal disorders  Researcher 
24. 18155  PhD Tomaž Vovk  Pharmacy  Researcher 
25. 18633  PhD Anamarija Zega  Pharmacy  Researcher 
26. 19281  PhD Zdenko Časar  Chemistry  Researcher 
27. 19317  PhD Lucija Peterlin Mašič  Pharmacy  Researcher 
28. 20374  PhD Mitja Kos  Pharmacy  Researcher 
29. 23420  PhD Jurij Trontelj  Pharmacy  Researcher 
30. 24400  PhD Janez Ilaš  Pharmacy  Researcher 
31. 24402  PhD Petra Kocbek  Pharmacy  Researcher 
32. 25490  PhD Matej Sova  Pharmacy  Researcher 
33. 26496  PhD Žiga Jakopin  Pharmacy  Researcher 
34. 26512  PhD Rok Frlan  Pharmacy  Researcher 
35. 28334  PhD Tihomir Tomašić  Pharmacy  Researcher 
36. 30816  PhD Izidor Sosič  Pharmacy  Researcher 
Description
The faculty's basic activity is pedagogical which comprises university program in pharmacy and a three-year program in clinical biochemistry. Within its scientific-research work, the faculty is engaged in researching and discovering new compounds, technologies, therapeutic systems as well as in gaining new knowledge, methodology and procedures in all phases of production and evaluation of a new medicine by considering professional standards (procedure validation, authority (state) requirements to medicine manufacturers within the principles of GLP (good laboratory practice), GMP (good manufacture practice) and GPP (good pharmacy practice). By its scientific-research work the faculty takes part in the development and strategic plans of the national pharmaceutical industry as well as in global research trends through international projects in the field of pharmacy. The main strategic goals of the faculty's further scientific-research development are: - researching and discovering new selective ligands for receptors and enzymes as well as new biocompatible materials which may become a future starting point for developing new substances and new pharmaceutical forms, respectively. - creating new knowledge and inventing new means and methods of compounds' characterization considering transportation and distribution of substances in models and biosystems of growing complexity, as well from the viewpoint of ligand-receptor interactions. - researching new therapeutic systems with designed properties. - researching new specific diagnostic tests and other methods for simulation and control of therapy. - researching optimal pharmacoepidemiologic and pharmacoeconomic parameters and new therapeutic approaches.
Confirmation required
Views history
Favourite